Sensex: 83,239.47 (0.05%)

Nifty: 25,412.65 (0.03%)

anubhai angaldas Securities Pvt. Ltd. Member: BSE - NSE - CDSL

Technology . Transparency . Trust

Contact Us
Apply For IPO

MARKET

IPO Synopsis
Akums Drugs & Pharmaceuticals Ltd
Registered Office: 304 Mohan Place LSC Saraswati, Vihar, Delhi - 110034, Delhi
Phone: 1
Email: 1
Website: 1
Initial public offer of 27,368,151* equity shares of face value of Rs. 2 each ("Equity Shares") of Akums Drugs and Pharmaceuticals Limited ("Company" or "Issuer") for cash at a price of Rs. 679^ per equity share (including a share premium of Rs. 677 per equity share) ("Offer Price") aggregating to Rs. 1856.74 crores*^ comprising a fresh issue of 10,037,716* equity shares aggregating to Rs. 680.00*^ crores by the company ("Fresh Issue") and an offer for sale of 17,330,435 equity shares aggregating to Rs. 1176.74 crores* ("Offered Shares") by the selling shareholders, comprising of 1,512,000 equity shares aggregating to Rs. 102.67 crores* by Sanjeev Jain, 1,512,000 equity shares aggregating to Rs. 102.67 crores* by Sandeep Jain (together the "Promoter Selling Shareholders") and 14,306,435 equity shares aggregating to Rs. 971.41 crores* by Ruby QC Investment Holdings Pte. Ltd. (The "Investor Selling Shareholder") (the promoter selling shareholders and the investor selling shareholder, collectively referred to as the "Selling Shareholders") ("Offer for Sale", together with the fresh issue, the "Offer"). This offer includes a reservation of 243,902* equity shares aggregating to Rs. 15.00 crores*^ for subscription by eligible employees (the "Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer constituted 17.39% and 17.23% of its post-offer paid-up equity share capital, respectively. The face value of equity shares is Rs. 2 each. The offer price is 339.50 times the face value of the equity shares. *Subject to finalization of basis of allotment ^After employee discount.
Issue Money Payable On
Opens On Closes On Application Allotment
30-Jul-2024 01-Aug-2024 679.00 - 0.00 0.00 - 0.00
Cr. Lead Managers to the Issue
Project Cost 637.37
Project Financed through Current Offer 1,856.74
Post Issue Equity Share Capital 31.48
Issue Price 679.00
Projects
Repayment/prepayment of all or certain borrowings of the company and subsidiary
Funding incremental working capital requirements of the company
Pursuing inorganic growth initiatives through acquisitions
General corporate purposes
Promoted By
Sanjeev Jain
Sandeep Jain
Akums Master Trust
BSE
NSE
Registrar to the Issue
Attention Investor
As per CDSL communiqué Kindly update your Email ID, Mobile Number & Income Range in CDSL demat Account on or before 31st May 2021, Non Compliance Account will be INACTIVE after 31st May 2021. | Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors.  | "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account." | "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."    Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of Investors.